Mechanistically, the cell differentiation mediated by JOA may be originated from the inhibition of BCR-ABL/c-MYC signaling in CML cells expressing wild-type BCR-ABL and BCR-ABL-T315I. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.